Background: Deprescribing by physicians based on the suggestions of community pharmacists is useful to ensure medication safety. Pharmacist-led deprescribing is not always implemented smoothly because of communication gaps between physicians and pharmacists. Our previous study found that assertiveness, as a communication style, is associated with pharmacist-initiated prescription changes for medication safety; however, its association with community pharmacist-led deprescribing is unclear.
Objectives: Our objective was to investigate which types of self-expression related to assertiveness are associated with community pharmacist-led deprescribing while adjusting for possible confounding factors.
Methods: We conducted a cross-sectional survey among community pharmacists between May and October 2022. Participants were community pharmacists belonging to a nationwide pharmacy chain in Japan who worked in 1 of 10 prefectures. The outcome variable was experience of community pharmacist-led deprescribing in the past year. Community pharmacists' self-expression related to assertiveness was assessed using the 3 subdomains of the Interprofessional Assertiveness Scale (IAS): nonassertive, assertive, and aggressive self-expression. Participants were classified into 1 of 2 categories based on median IAS subdomain scores. Pharmacist characteristics were compared by group in univariate analyses. Binomial logistic regression was used to examine the association between experience of community pharmacist-led deprescribing and community pharmacists' assertiveness.
Results: Of the 3346 community pharmacists invited, 963 were included in the analysis. After adjustment, high assertive self-expression was associated with experience of community pharmacist-led deprescribing (adjusted odds ratio, 1.49; 95 % confidence interval, 1.02-2.20; p = 0.042). No associations were found between experience of community pharmacist-led deprescribing and nonassertive or aggressive self-expression.
Conclusions: Community pharmacists with higher levels of assertive self-expression were more likely to experience community pharmacist-led deprescribing.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.sapharm.2025.03.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assertiveness in community pharmacists and their experience of pharmacist-led deprescribing: A cross-sectional study.
Res Social Adm Pharm
March 2025
Department of Primary Care and Medical Education, Institute of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. Electronic address:
Background: Deprescribing by physicians based on the suggestions of community pharmacists is useful to ensure medication safety. Pharmacist-led deprescribing is not always implemented smoothly because of communication gaps between physicians and pharmacists. Our previous study found that assertiveness, as a communication style, is associated with pharmacist-initiated prescription changes for medication safety; however, its association with community pharmacist-led deprescribing is unclear.
View Article and Find Full Text PDFProtocol to evaluate the feasibility of the D-PRESCRIBE intervention adapted to the Belgian community setting (END-IT CS study).
BMJ Open
March 2025
Clinical Pharmacy and Pharmacoepidemiology research group, UCLouvain Louvain Drug Research Institute, Brussels, Belgium
Introduction: Benzodiazepine receptor agonists (BZRA) deprescribing interventions are needed to tackle high BZRA use in the older population. This study aims to assess the feasibility of the D-PRESCRIBE intervention, adapted from Canada to the Belgian community setting. This pharmacist-led intervention comprises a patient educational brochure and a pharmacist-to-prescriber communication tool.
View Article and Find Full Text PDFDeprescribing in Australian residential aged care facilities: A scoping review.
Australas J Ageing
March 2025
Calvary Health Care Bethlehem, Caulfield South, Victoria, Australia.
Objectives: Older adults residing in residential aged care facilities (RACFs) are particularly vulnerable to negative health outcomes from polypharmacy and suboptimal prescribing in the context of frailty and multimorbidity. Deprescribing, the intentional withdrawal of inappropriate medications, has been proposed as a promising approach to reduce polypharmacy-related harms. Examining current deprescribing interventions in RACFs would help identify gaps in research knowledge.
View Article and Find Full Text PDFAligning Medications With What Matters Most: Conversations Between Pharmacists, People With Dementia, and Care Partners.
J Am Geriatr Soc
February 2025
Davis Department of Medicine, University of California, Sacramento, California, USA.
Introduction: Successful deprescribing for people with dementia (PWD) depends on communication about medication-related priorities between PWD, care partners and clinicians. The objective of this study was to gain in-depth knowledge of how elicitation of PWD and care partner medication-related priorities during a deprescribing intervention shaped discussions with pharmacists about medications.
Methods: Qualitative analysis of audio-recorded interactions between pharmacists and patient-care partner dyads in a pilot study of a pharmacist-led deprescribing intervention for PWD in primary care.
Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) - A multi-centre, non-randomised, feasibility study protocol.
NIHR Open Res
January 2025
Centre for Health Services Studies, University of Kent, Canterbury, England, CT2 7NF, UK.
Background: Opioids are frequently prescribed for short-term acute pain following surgery. Used appropriately, opioids deliver extremely favourable pain relief. Used longer than 90-days, however, can result in health complications, including unintentional overdose and addiction.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!